High dose folic acid treatment of fragile (X) males.
We conducted an experimental trial of high-dose folic acid given to five males, ages 8 to 26 years, with the fra(X) syndrome. In this double blind study, each subject received 250 mg per day of folic acid for 3 months, followed by placebo for 3 months, and folic acid again for an additional three months. Based on IQ tests, behavior ratings, the Autistic Descriptors Checklist, and parental ratings, there was little evidence to suggest any positive effects seen during the administration of high-dose folic acid. Therefore, this study has provided little support for a hypothesis of benefit of high-dose folic acid in the treatment of the fra(X) syndrome.
D000293:Adolescent; D000328:Adult; D001519:Behavior / Q000187:drug effects; D002648:Child; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005492:Folic Acid / Q000008:administration & dosage* / Q000627:therapeutic use; D005600:Fragile X Syndrome / Q000188:drug therapy* / Q000523:psychology; D006801:Humans; D007360:Intelligence / Q000187:drug effects; D008297:Male; D012729:Sex Chromosome Aberrations / Q000188:drug therapy*
D005492:Folic Acid